Anticancer therapy: MiRNA-9600 increases the expression of tumor suppressor protein Grainyhead transcription factor-3 (GRHL3), inhibits proliferation, and promotes apoptosis of cancer cells via down regulation of its target gene, 14/December/2016, 9.49 pm

Natural product-derived therapy for overcoming chemoresistance in Human cancers: Cirsilol (3′,4′,5-trihydroxy-6,7-dimethoxyflavone), a flavone isolated from Achillea fragrantissima, increases the expression of CADM1, decreases BMI1 translocation, increases tumor suppressor INK4a/p16 expression and restores chemosensitivity in drug-resistant Human cancers via down regulation of its target gene, 14/December/2016, 9.43 pm
December 14, 2016
Natural product-derived therapy for Human Leukemias: Cucurbitacin E, found abundantly in Watermelons, suppresses B-Cell and myeloid leukemias via up regulation of the tumor suppressor IRF4, 14/December/2016, 10.19 pm
December 14, 2016
Show all

Research findings to Therapeutic opportunity:  

The study presented here suggests that MiRNA-9600, by decreasing the expression of its target genes, it may increase the expression of tumor suppressor GRHL3.

price-2

[easy_payment currency=”USD”]

Thereby, it may inhibit proliferation, and promote apoptosis of cancer cells. Thus, pharmacological formulations encompassing MiRNA-9600 activators” may be used to inhibit cancer progression.


Details of the research findings

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Undisclosed mechanistic information: How MiRNA-9600  increases the expression of tumor suppressor protein GRHL3?

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Amount: $2

For purchase and payment details, you may reach us at info@genomediscovery.org


References

CitationBoominathan, L., Anticancer therapy: MiRNA-9600 increases the expression of tumor suppressor protein Grainyhead transcription factor-3 (GRHL3), inhibits proliferation, and promotes apoptosis of cancer cells via down regulation of its target gene, 14/December/2016, 9.48 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org or newbioideas.com

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.